Financial Data and Key Metrics Changes - In Q1 2025, the company generated revenue of $6 million, a slight increase from $5.9 million in Q1 2024, primarily driven by the SK On agreement and milestone execution [9] - Operating expenses decreased to $30 million, down by $1.7 million compared to Q1 2024, attributed to lower direct labor costs [9] - The operating loss was $24 million, with a net loss of $15 million or 8 cents per share [10] - Total liquidity at the end of the quarter was $300 million, with contract receivables of $2.2 million and total current liabilities of $10.4 million [10][11] Business Line Data and Key Metrics Changes - The company is focused on electrolyte development, with plans to install a continuous manufacturing pilot line at SP2, expected to expand production capacity to 75 metric tons per year [4] - The company is close to completing factory acceptance testing for the SK On line, a key milestone in their line installation agreement [6] - There is ongoing innovation in the Electrolyte Innovation Center, which is being used to develop and test production processes [7] Market Data and Key Metrics Changes - Customer engagement and electrolyte sampling activities have shown positive trends, indicating demand for multiple generations of the electrolyte from both existing and potential new customers [8] Company Strategy and Development Direction - The company aims to balance financial discipline with appropriate investments in technology development and process improvement [11] - The strategic focus includes executing agreements with Eskayon for solid state cell development and ramping up electrolyte sampling to identify long-term customers [5][7] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the transition from traditional lithium-ion to solid-state battery technology, highlighting the importance of customer feedback in driving electrolyte performance improvements [6][8] - The company anticipates significant electrolyte revenue growth starting as early as 2027, with the bulk of revenues expected around 2029 and beyond [20] Other Important Information - The company received $1.5 million in reimbursements under an agreement with the U.S. Department of Energy during the quarter [5][22] Q&A Session Summary Question: How to think about 2025 revenue and timing around revenue from customers for electrolytes? - Management indicated that 2025 revenue is primarily driven by collaborative arrangements, particularly with SK On, and government contracts, with electrolyte sampling at a lower level [15][16] Question: What is the trajectory of revenues potentially beyond 2025? - Management noted that customers are in early stages of cell development, with increased sampling but not large quantities yet, and significant revenue is expected around 2027 to 2030 [19][20] Question: Update on the DOE grant? - Management clarified that the $1.5 million received is a grant, not a loan, and that is the current status [22]